Condition: Spinocerebellar Ataxia (SCA) · Spinocerebellar Ataxia Type 6 · Sponsor: University of California, San Francisco
The goal of this clinical trial is to test the safety of placing Deep Brain Stimulators (DBS) in the cerebellum and using electrical stimulation of that part of the brain to treat symptoms related to the participants spinocerebellar ataxia. Five adults diagnosed with spinocerebellar ataxia type 6 (SCA6) with inadequate cerebellar symptom relief will be implanted with a Medtronic Percept Primary Cell Neurostimulator. The device will be implanted into the dentate nucleus, which is a structure located within the cerebellum that is responsible for controlling movement and balance. Specifically, the investigators will be using adaptive deep brain stimulation (aDBS), which analyzes brain signals and automatically adjusts the strength, timing, and pattern of stimulation according to the patient's needs at any given moment. This study will evaluate the feasibility, safety, and tolerability of aDBS in SCA6 patients.
This description comes directly from the study's public registry record.
Marta San Luciano Palenzuela, MD, PhD · (415) 353-2311 · Marta.SanLucianoPalenzuela@ucsf.edu
Karson J Franjieh, BS · 415-755-8954 · karson.franjieh@ucsf.edu
Always discuss trial participation with your own doctor first.
| UCSF Weill Institute for Neurosciences | San Francisco, California, United States | Recruiting |
| University of California, San Francisco | San Francisco, California, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07288437